z-logo
open-access-imgOpen Access
The Urgent Need for Molecular Imaging to Confirm Target Engagement for Clinical Trials of Fragile X Syndrome and Other Subtypes of Autism Spectrum Disorder
Author(s) -
James Robert Bras̆ić,
Anil Mathur,
Dejan B. Budimirovic
Publication year - 2019
Publication title -
archives of neuroscience
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.116
H-Index - 3
eISSN - 2322-5769
pISSN - 2322-3944
DOI - 10.5812/ans.91831
Subject(s) - fragile x syndrome , clinical trial , autism spectrum disorder , autism , medicine , broad spectrum , cognition , fragile x , clinical psychology , neuroscience , psychology , psychiatry , pathology , biology , chemistry , combinatorial chemistry , gene , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom